id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-S-0036-0178,FDA,FDA-1995-S-0036,"Public Disclosure Report from Kelly Hoy, Diffusion Pharmaceuticals Inc",Other,Public Disclosure,2019-09-23T04:00:00Z,2019,9,2019-09-23T04:00:00Z,,2019-09-23T12:37:21Z,,0,0,0900006483d2bc1d
FDA-1995-S-0036-0179,FDA,FDA-1995-S-0036,"Public Disclosure Report from Kelly Hoy, Diffusion Pharmaceuticals Inc",Other,Public Disclosure,2019-09-23T04:00:00Z,2019,9,2019-09-23T04:00:00Z,,2019-09-23T12:41:23Z,,0,0,0900006483faba35